Varda raises a $187M Series C

Varda Space Industries

Varda Space Industries raised $187 million in a Series C led by Natural Capital and Shrug Capital, bringing total funding to $329 million. The capital supports scaling pharmaceutical manufacturing in microgravity, with plans for additional orbital missions and expansion of manufacturing capabilities for complex biologics.

• Series C led by Natural Capital and Shrug Capital; participation from Founders Fund, Peter Thiel, Khosla Ventures, Lux Capital.
• Total funding to date: $329 million.
• Focus: scaling in-orbit pharmaceutical manufacturing, particularly for monoclonal antibodies (market value $200B+).
• Track record: 3 successful mission launches and returns since 2023; 4th mission in orbit, 5th planned before year-end.